Cheryl Kefauver

Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine

William Blum, Ramiro Garzon, Rebecca B. Klisovic et al. · Proceedings of the National Academy of Sciences · 2010 · 453 citations · Full text

Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia

William Blum, Rebecca B. Klisovic, Bjoern Hackanson et al. · Journal of Clinical Oncology · 2007 · 319 citations

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

Kimberly A. Varker, Jennifer E. Biber, Cheryl Kefauver et al. · Annals of Surgical Oncology · 2007 · 142 citations

Metastatic Malignant Melanoma, Medicine, Melanoma +5

Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia

Leslie A. Andritsos, Amy J. Johnson, Gerard Lozanski et al. · Journal of Clinical Oncology · 2008 · 141 citations · Full text

Phase I Study of Oblimersen Sodium, an Antisense to Bcl-2, in Untreated Older Patients With Acute Myeloid Leukemia: Pharmacokinetics, Pharmacodynamics, and Clinical Activity

Guido Marcucci, Wendy Stock, Guowei Dai et al. · Journal of Clinical Oncology · 2005 · 140 citations · Full text